These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3568534)

  • 1. Influence of baseline hemodynamic status and sympathetic activity on the response to nicardipine, a new dihydropyridine, in patients with hypertension or chronic congestive heart failure.
    Ryman KS; Kubo SH; Shaknovich A; Cody RJ
    Clin Pharmacol Ther; 1987 May; 41(5):483-9. PubMed ID: 3568534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of invasive ergometric exercise to assess the hemodynamic response to nicardipine.
    Cody RJ
    Am J Cardiol; 1987 Jun; 59(17):20J-24J. PubMed ID: 3604921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure.
    Ryman KS; Kubo SH; Lystash J; Stone G; Cody RJ
    Am J Cardiol; 1986 Sep; 58(7):583-8. PubMed ID: 3751928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hemodynamic effects of nicardipine in patients with chronic congestive heart failure].
    Tondi S; Zennaro RG; Masciocco L; Mattioli G
    Cardiologia; 1989 Dec; 34(12):1013-9. PubMed ID: 2634477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure.
    Burlew BS; Gheorghiade M; Jafri SM; Goldberg AD; Goldstein S
    Am Heart J; 1987 Oct; 114(4 Pt 1):793-804. PubMed ID: 3310565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
    Rauch B; Zimmermann R; Kapp M; Haass M; Von Molitor S; Smolarz A; Neumann FJ; Kübler W; Dietz R; Tillmanns H
    Clin Cardiol; 1991 May; 14(5):386-95. PubMed ID: 2049889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. IV Nicardipine Study Group.
    Chest; 1991 Feb; 99(2):393-8. PubMed ID: 1989801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and pulmonary hemodynamic responses to nicardipine during graded ergometric exercise in patients with moderate to severe essential hypertension.
    Cody RJ; Kubo SH; Ryman KS; Shaknovich A; Laragh JH
    J Am Coll Cardiol; 1987 Sep; 10(3):647-54. PubMed ID: 3624670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
    Sy J; Vitarelli A; Gheorghiade M
    Minerva Cardioangiol; 1993 Nov; 41(11):535-41. PubMed ID: 8127455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delayed-action nicardipine in the prolonged treatment of chronic congestive heart failure in responsive subjects].
    Mattioli AV; Masciocco L; Tondi S; Mattioli G
    Cardiologia; 1989 Dec; 34(12):1021-5. PubMed ID: 2634478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of intravenous nicardipine in severely pre-eclamptic women with a hypertensive crisis.
    Cornette J; Buijs EA; Duvekot JJ; Herzog E; Roos-Hesselink JW; Rizopoulos D; Meima M; Steegers EA
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):89-95. PubMed ID: 25721057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of a calcium-mediated vasoconstrictor component in patients with congestive heart failure.
    Cody RJ; Riew KD; Kubo SH
    Clin Pharmacol Ther; 1989 Sep; 46(3):291-6. PubMed ID: 2550168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques for assessing inotropic effects of drugs in patients with heart failure: application to the evaluation of nicardipine.
    Fifer MA; Aroney CN; Semigran MJ; Herrmann HC; Dec GW; Boucher CA
    Am Heart J; 1990 Feb; 119(2 Pt 2):451-6. PubMed ID: 2405615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous nicardipine in the treatment of postoperative arterial hypertension.
    Vincent JL; Berlot G; Preiser JC; Engelman E; Dereume JP; Khan RJ
    J Cardiothorac Vasc Anesth; 1997 Apr; 11(2):160-4. PubMed ID: 9105985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine.
    Singh BN; Josephson MA
    Am Heart J; 1990 Feb; 119(2 Pt 2):427-34. PubMed ID: 1967896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of dibutyryl cyclic AMP on renal circulation in congestive heart failure.
    Hoshino Y
    Jpn Heart J; 1988 Nov; 29(6):771-9. PubMed ID: 2853776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical, hemodynamic, angiographic, and neurohumoral responses to vasodilation with felodipine in patients with chronic congestive heart failure.
    Kassis E; Amtorp O
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):347-52. PubMed ID: 1691355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the haemodynamic responses to exercise, posture and nitrates after treatment of congestive heart failure with an arteriolar vasodilator.
    Thomas P; Dixon MS; Culling W; Sheridan DJ
    Clin Sci (Lond); 1989 Sep; 77(3):229-36. PubMed ID: 2509126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.